CD44 and breast cancer: Indeed, miR-7 modulates the histone methyl transferase SETDB1, regulating a STAT3-dependent EMT, and acquisition of SC traits in CD44+ cells derived from MDA-MB-231 human breast cancer cells (Zhang et al., 2014).